Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lung Neoplasms 3 Prostatic Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Spinal Fractures 1 Radiation Injuries 1 Primary Myelofibrosis 1 Polyps 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Osteoporosis 1 Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid 1 Heart Diseases 1 Gingivitis 1 Focal Liver Lesions 1 Disease 1 Colorectal Neoplasms 1 Colonic Polyps 1 Colonic Neoplasms 1 Colonic Diseases 1 Colitis 1 Childhood Brain Neoplasm 1 Atrial Fibrillation 1 Arrhythmias, Cardiac 1

Interventions

Tretinoin 27 Arsenic Trioxide 27 Cytarabine 20 Cyclophosphamide 14 Methotrexate 13 Idarubicin 13 Busulfan 11 Filgrastim 10 Etoposide 8 fludarabine phosphate 7 Peripheral Blood Stem Cell Transplantation 7 Mercaptopurine 7 Gemtuzumab 7 Daunorubicin 7 Radiotherapy 6 Tacrolimus 5 Mitoxantrone 5 Clofarabine 5 Vorinostat 4 Topotecan 4 Sorafenib 4 Antilymphocyte Serum 4 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Bortezomib 3 Azacitidine 3 venetoclax 2 tamibarotene 2 sargramostim 2 romidepsin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Promyelocytic, Acute × Diagnosis × Clear all

NCT04562818 2020-09-24

Mexico APL

Instituto Nacional de Cancerologia de Mexico

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡